Skip to main content

Advertisement

SpringerLink
Log in

Lymph node dissection for lung cancer: past, present, and future

  • Current Topics Review Article
  • Published:
General Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

In 1978, Naruke et al. proposed an anatomical map that included numbered lymph node stations, which then became widely used for nodal dissection. In 1997, Mountain and Dresler published a new map, which is now favored by the American Thoracic Society and the European Respiratory Society. Using these maps, regional nodal dissection has been universally performed in lung cancer surgery. Clear evidence regarding the survival benefit of lymph node dissection for lung cancer is lacking. However, lobectomy with lymph node dissection continues to be a standard surgical procedure for lung cancer because lymph node dissection is an important investigative process in staging patients. Over the last decade, the extent of nodal dissection for lung cancer has changed due to the increasing number of early detected lung cancers made possible by the recent development of the CT scanner. This manuscript describes the history, present strategy, and future perspectives of lymph node dissection for lung cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Cahan WG. Radical lobectomy. J Thorac Cardiovasc Surg. 1960;39:555–72.

    CAS  PubMed  Google Scholar 

  2. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thoracic Cardiovasc Surg. 1978;76:832–9.

    CAS  Google Scholar 

  3. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest. 1997;111:1718–23.

    Article  CAS  PubMed  Google Scholar 

  4. American Thoracic Society. Clinical staging of primary lung cancer. Am Rev Respir Dis. 1983;127:659–64.

    Google Scholar 

  5. American Thoracic Society. European Respiratory Society. Pretreatment evaluation of non-small cell lung cancer. Am J Respir Crit Care Med. 1997;156:320–2.

    Article  Google Scholar 

  6. Cahan WG, Watson WL, Pool JL. Radical pneumonectomy. J Thorac Surg. 1951;22:449–73.

    CAS  PubMed  Google Scholar 

  7. Nohl HC. An investigation into the lymphatic and vascular spread of carcinoma of the bronchus. Thorax. 1956;11:172–85.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. The Japan Lung Cancer Society. Classification of lung cancer. First English edition. Tokyo: Kanehara & Co. Ltd.; 2000.

  9. Goldstraw P. Report on the international workshop on intrathoracic staging, London, October 1996. Lung Cancer. 1997;18:107–11.

    Article  Google Scholar 

  10. The International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med. 2004;22:3860–7.

    Google Scholar 

  11. Winton TL, Livingston R, Johnson D, Rigas J, Johnston M, Butts C, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med. 2005;352:2589–97.

    Article  CAS  PubMed  Google Scholar 

  12. Lardinois D, De Leyn P, Van Schil P, Porta RR, Waller D, Passlick B, et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg. 2006;30:787–92.

    Article  PubMed  Google Scholar 

  13. Gajra A, Newman N, Gamble GP, Kohman LJ, Graziano SL. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol. 2003;21:1029–34.

    Article  PubMed  Google Scholar 

  14. Doddoli C, Aragon A, Barlesi F, Chetaille B, Robitail S, Giudicelli R, et al. Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer? Eur J Cardiothorac Surg. 2005;27:680–5.

    Article  PubMed  Google Scholar 

  15. Massard G, Ducrocq X, Kochetkova EA, Porhanov VA, Riquet M. Sampling or node dissection for intraoperative staging of lung cancer: a multicentric cross-sectional study. Eur J Cardiothorac Surg. 2006;30:164–7.

    Article  PubMed  Google Scholar 

  16. Keller SM, Adak S, Wagner H, Johnson DH. Mediastinal lymph node dissection improves survival in patients with stage II and IIIa non-small cell lung cancer. Ann Thorac Surg. 2000;70:358–66.

    Article  CAS  PubMed  Google Scholar 

  17. Dales RE, Stark RM, Raman S. Computed tomography to stage lung cancers: approaching a controversy using meta-analysis. Am Rev Respir Dis. 1990;141:1096–101.

    Article  CAS  PubMed  Google Scholar 

  18. Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s––meta-analytic comparison of PET and CT. Radiology. 1999;213:530–6.

    Article  CAS  PubMed  Google Scholar 

  19. Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer. A meta-analysis. Ann Int Med. 2003;139:879–900.

    Article  PubMed  Google Scholar 

  20. Hellwig D, Ukena D, Paulsen F, Bamberg M, Kirsch CM, Onko-PET der Deutschen Gesellschaft fur Nuklearmedizin. Meta-analysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose in lung tumors. Basis for discussion of the German Consensus Conference on PET in Oncology 2000. Pneumologie. 2001;55:367–77.

    Article  CAS  PubMed  Google Scholar 

  21. Oda M, Watanabe Y, Shimizu J, Murakami S, Ohta Y, Sekido N, et al. Extent of mediastinal node metastasis in clinical stage I non-small-cell lung cancer: the role of systematic nodal dissection. Lung Cancer. 1998;22:23–30.

    Article  CAS  PubMed  Google Scholar 

  22. Mountain CF. A new international staging system for lung cancer. Chest. 1986;89:225S–33S.

    Article  CAS  PubMed  Google Scholar 

  23. Mountain CF. Revisions in the international system for staging lung cancer. Chest. 1997;111:1710–7.

    Article  CAS  PubMed  Google Scholar 

  24. Watanabe S, Asamura H, Suzuki K, Tsuchiya R. Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer. Ann Thorac Surg. 2005;79:1682–5.

    Article  PubMed  Google Scholar 

  25. Graham AN, Chan KJ, Pastorino U, Goldstraw P. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer. J Thoracic Cardiovasc Surg. 1999;117:246–51.

    Article  CAS  Google Scholar 

  26. Watanabe S, Oda M, Go T, Tsunezuka Y, Ohta Y, Watanabe Y, et al. Should mediastinal nodal dissection be routinely undertaken in patients with peripheral small-sized lung cancer? Retrospective analysis of 225 patients. Eur J Cardiothorac Surg. 2001;20:1007–11.

    Article  CAS  PubMed  Google Scholar 

  27. Takizawa T, Terashima M, Koike T, Akamatsu H, Kurita Y, Yokoyama A. Mediastinal lymph node metastasis in patients with clinical stage I peripheral non-small-cell lung cancer. J Thorac Cardiovasc Surg. 1997;113:248–52.

    Article  CAS  PubMed  Google Scholar 

  28. Misthos P, Sepsas E, Athanassiadi K, Kakaris S, Skottis I. Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer. Eur J Cardiothorac Surg. 2004;25:502–8.

    Article  CAS  PubMed  Google Scholar 

  29. Gunluoglu Z, Solak O, Metin M, Gurses A. The prognostic significance of skip mediastinal lymphatic metastasis in resected non-small cell lung cancer. Eur J Cardiothorac Surg. 2002;21:595.

    Article  CAS  PubMed  Google Scholar 

  30. Riquet M, Hidden G, Debesse B. Direct lymphatic drainage of lung segments to the mediastinal nodes. An anatomic study on 260 adults. J Thorac Cardiovasc Surg. 1989;97:623–32.

    CAS  PubMed  Google Scholar 

  31. Yoshino I, Yokoyama H, Yano T, Ueda T, Takai E, Mizutani K, et al. Skip metastasis to the mediastinal lymph nodes in non-small cell lung cancer. Ann Thoracic Surg. 1996;62:1021–5.

    Article  CAS  Google Scholar 

  32. Prenzel KL, Monig SP, Sinning JM, Baldus SE, Gutschow CA, Grass G, et al. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancers. J Surg Oncol. 2003;82:256–60.

    Article  PubMed  Google Scholar 

  33. Pignon JP, Tribodet H, Scagliotti G, Douillard JY, Shepherd FA, Stephens RJ, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group. J Clin Oncol. 2008;26:3552–9.

    Article  PubMed  Google Scholar 

  34. Darling GE, Allen MS, Decker PA, et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg. 2011;141:662–70.

    Article  PubMed  Google Scholar 

  35. Bollen EC, van Duin CJ, Theunissen PH, vt Hof-Grootenboer BE, Blijham GH. Mediastinal lymph node dissection in resected lung cancer: morbidity and accuracy of staging. Ann Thorac Surg. 1993;55:961–6.

    Article  CAS  PubMed  Google Scholar 

  36. Thomas PA, Piantadosi S, Mountain CF. The Lung Cancer Study Group. Should subcarinal lymph nodes be routinely examined in patients with non-small cell lung cancer? J Thorac Cardiovasc Surg. 1988;95:883–7.

    Google Scholar 

  37. Izbicki JR, Passlick B, Karg O, Bloechle C, Pantel K, Knoefel WT, et al. Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer. Ann Thorac Surg. 1995;59:209–14.

    Article  CAS  PubMed  Google Scholar 

  38. Watanabe S, Oda M, Tsunezuka Y, Go T, Ohta Y, Watanabe G. Peripheral small-sized (2 cm or less) non-small cell lung cancer with mediastinal lymph node metastasis; clinicopathologic features and patterns of nodal spread. Eur J Cardiothorac Surg. 2002;22:995–9.

    Article  PubMed  Google Scholar 

  39. Kawano R, Hata E, Ikeda S, Sakaguchi H. Micrometastasis to lymph nodes in stage I left lung cancer patients. Ann Thorac Surg. 2002;73:1558–62.

    Article  PubMed  Google Scholar 

  40. Lardinois D, Suter H, Hakki H, Rousson V, Betticher D, Ris HB. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer. Ann Thorac Surg. 2005;80:268–74.

    Article  PubMed  Google Scholar 

  41. Naruke T, Goya T, Tsuchiya R, Suemasu K. The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis. Ann Thorac Surg. 1988;46:603–10.

    Article  CAS  PubMed  Google Scholar 

  42. Watanabe Y, Hayashi Y, Shimizu J, Oda M, Iwa T. Mediastinal nodal involvement and the prognosis of non-small cell lung cancer. Chest. 1991;100:422–8.

    Article  CAS  PubMed  Google Scholar 

  43. Nakahara K, Fujii Y, Matsumura A, Minami M, Okumura M, Matsuda H. Role of systematic mediastinal dissection in N2 non-small cell lung cancer patients. Ann Thorac Surg. 1993;56:331–5.

    Article  CAS  PubMed  Google Scholar 

  44. Pearson FG. Non-small cell lung cancer: role of surgery for stages I–III. Chest. 1999;116:500S–3S.

    Article  CAS  PubMed  Google Scholar 

  45. Keller SM, Vangel MG, Wagner H, Schiller JH, Herskovic A, Komaki R, et al. Eastern Cooperative Oncology Group. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease. J Thorac Cardiovasc Surg. 2004;128:130–7.

    Article  PubMed  Google Scholar 

  46. Izbicki JR, Passlick B, Pantel K, Pichlmeier U, Hosch SB, Karg O, et al. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small lung cancer. Ann Surg. 1998;227:138–44.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  47. Sugi K, Nawata K, Fujita N, Ueda K, Tanaka T, Matsuoka T, et al. Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2 cm in diameter. World J Surg. 1998;22:290–5.

    Article  CAS  PubMed  Google Scholar 

  48. Wu Y, Huang ZF, Wang SY, Yang XN, Ou W. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer. 2002;36:1–6.

    Article  PubMed  Google Scholar 

  49. Wright G, Manser RL, Bymes G, Hart D, Campbell DA. Surgery for non-small cell lung cancer: systematic review and meta-analysis of randomised controlled trials. Thorax. 2006;61:597–603.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  50. Detterbeck F. What do with “surprise” N2? Intraoperative management of patients with non-small cell lung cancer. J Thorac Oncol. 2008;3:289–302.

    Article  PubMed  Google Scholar 

  51. The CONSORT statement. Web site: http://www.consort-statement.org.

  52. Watanabe S, Ladas G, Goldstraw P. Inter-observer variability in systematic nodal dissection: comparison of European and Japanese nodal designation. Ann Thorac Surg. 2002;73:245–8.

    Article  PubMed  Google Scholar 

  53. Sobin LH, Gospodarowicz M, Wittekind CH, UICC International Union Against Cancer, editors. TNM classification of malignant tumours. 7th ed. New York: Wiley-Liss; 2009.

  54. Luzzi L, Paladini P, Ghiribelli C, Voltolini L, Di Bisceglie M, D’Agata A, et al. Assessing the prognostic value of the extent of mediastinal lymph node infiltration in surgically treated non-small cell lung cancer (NSCLC). Lung Cancer. 2000;30:99–105.

    Article  CAS  PubMed  Google Scholar 

  55. Asamura H, Nakayama H, Kondo H, Tsuchiya R, Naruke T. Lobe-specific extent of systematic lymph node dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis. J Thorac Cardiovasc Surg. 1999;117:1102–11.

    Article  CAS  PubMed  Google Scholar 

  56. Okada M, Sakamoto T, Yuki T, Mimura T, Miyoshi K, Tsubota N. Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer. Ann Thorac Surg. 2006;81:1028–32.

    Article  PubMed  Google Scholar 

  57. Okada M, Tsubota N, Yoshimura M, Miyamoto Y. Proposal for reasonable mediastinal lymphadenectomy in bronchogenic carcinomas: role of subcarinal nodes in selective dissection. J Thorac Cardiovasc Surg. 1998;116:949–53.

    Article  CAS  PubMed  Google Scholar 

  58. Watanabe S, Asamura H, Suzuki K, Tsuchiya R. The new strategy of selective nodal dissection for lung cancer based on segment-specific patterns of nodal spread. Interact Cardiovasc Thorac Surg. 2005;4:106–9.

    Article  PubMed  Google Scholar 

  59. Cerfolio RJ, Bryant AS. Distribution and likelihood of lymph node metastasis based on the lobar location of nonsmall-cell lung cancer. Ann Thorac Surg. 2006;81:1969–73.

    Article  PubMed  Google Scholar 

  60. Naruke T, Tsuchiya R, Kondo H, Nakayama H, Asamura H. Lymph node sampling in lung cancer. How should it be done? Eur J Cardiothorac Surg. 1999;16(Suppl 1):17–24.

    Article  Google Scholar 

  61. Rami-Porta R, Wittekind C, Goldstraw P. Complete resection in lung cancer surgery: proposed definition. Lung Cancer. 2005;49:25–33.

    Article  PubMed  Google Scholar 

  62. Ginsberg RJ. Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas. J Thorac Cardiovasc Surg. 1996;111:1123–4.

    Article  CAS  PubMed  Google Scholar 

  63. Allen MS, Darling GE, Pechet TT, Mitchell JD, Herndon JE 2nd, Landreneau RJ, et al. Morbidity and mortality of major pulmonary resections in patients with early stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg. 2006;81:1013–9.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The author has declared that no conflict of interest exists.

Author information

Authors and Affiliations

  1. Division of Thoracic Surgery, National Cancer Center Hospital, Tsukiji 5-1-1, Tokyo, 104-0045, Japan

    Shun-ichi Watanabe

Authors
  1. Shun-ichi Watanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shun-ichi Watanabe.

Additional information

This review was submitted at the invitation of the editorial committee.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Watanabe, Si. Lymph node dissection for lung cancer: past, present, and future. Gen Thorac Cardiovasc Surg 62, 407–414 (2014). https://doi.org/10.1007/s11748-014-0412-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11748-014-0412-z

Keywords

Search

Navigation